In the current study, we use retrospective analysis of human cancer transcriptomic and clinical data in combination with functional studies in human cell models to investigate the significance of altered PER1 expression in LKB1-mutant lung adenocarcinoma. This evidence concerns the gene STK11 and lung adenocarcinoma.